Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

Vaccine

Volumn 19, Issue 27, 2001, Pages 3681-3691

  Okuda, Kenji ^a   Ihata, Atsushi ^a   Watabe, Setsuko ^a   Okada, Eiichi ^a   Yamakawa, Tadashi ^a   Hamajima, Kenji ^a   Yang, Jun ^a   Ishii, Norihisa ^a   Nakazawa, Masatoshi ^a   Okuda, Katsuji ^b   Ohnari, Katsuhiro ^c   Nakajima, Katsuhisa ^d   Xin, Ke Qin ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c Yokohama Minami Kyosai Hospital   (Japan)

^d NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

DNA plasmid; Influenza A virus; Influenza M gene

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; INFLUENZA VACCINE; PLASMID DNA; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; GENE EXPRESSION; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA VIRUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; VIRUS GENE; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DNA, VIRAL; DOGS; INFLUENZA A VIRUS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; VACCINES, DNA; VIRAL MATRIX PROTEINS;

EID: 0035859291     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00078-0     Document Type: Article

References (36)

1. Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus
2. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines
3. Protection against mycoplasma infection using expression-library immunization
4. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
5. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
6. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products
7. Genetic control of immune responses to HIV-1 env DNA vaccine
8. A universal influenza A vaccine based on the extracellular domain of the M2 protein
9. Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains
10. Acceleration of influenza virus clearance by the Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein
11. Heterologous protection against influenza by injection of DNA encoding a viral protein
12. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
13. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, b2-microglobulin-deficient, and J chain-deficient mice
14. Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites
15. Antigenic structure of myoglobin: The complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins
16. Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens
17. Antiviral activity of influenza virus M1 zinc finger peptides
18. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodificiency virus type 1
19. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: Either CD4+ or CD8+ T cells can promote survival and recovery after challenge
20. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry
21. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individual
22. Detection and quantitiation of cells secreting IL-16 under physiologic conditions in BALB/c mice
23. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: Interferon gamma, but not tumour necrosis factor a, displays antiviral activity in vivo
24. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs
25. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine
26. Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin
27. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin
28. In vivo induction of cytotoxic T lymphocytes specific for a single epitope introduced into an unrelated molecule
29. Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin
30. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza
31. Potential DNA vaccine integration into host cell genome
32. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement
33. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
34. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires congnate CD4+ T cell help
35. b2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes
36. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA